Clinical Trial Update: Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of SLC022 for pain associated with postherpetic neuralgia. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• SLC022

Snippet

Sponsor: Solace Pharmaceuticals | Conditions: Postherpetic Neuralgia | Phase 2 | Status: UNKNOWN